Pine Pharmaceuticals, LLC

19 FDA enforcement actions

19 Total Recalls

0 Class I

18 Class II

1 Class III

Firm Details

Product Types: drug
States: NY

All Recalls

Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class II: Risk 10/02/2023 drug

Lack of Assurance of Sterility
Class III: Low Risk 03/27/2023 drug

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
Class II: Risk 12/22/2022 drug

CGMP Deviations: Raw material recalled by repackager, due to discoloration.
Class II: Risk 07/27/2022 drug

Lack of Assurance of Sterility

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.